Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells
Shangwen Jing,1,* Yantong Lu,1,2,* Jing Zhang,1 Yan Ren,1,2 Yousheng Mo,3 Dongdong Liu,3 Lining Duan,4 Zhongyu Yuan,5 Changjun Wang,2 Qi Wang1 1Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China; 2Guangdong Provin...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-09-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/levistilide-a-induces-ferroptosis-by-activating-the-nrf2ho-1-signaling-peer-reviewed-fulltext-article-DDDT |
| _version_ | 1811262119058866176 |
|---|---|
| author | Jing S Lu Y Zhang J Ren Y Mo Y Liu D Duan L Yuan Z Wang C Wang Q |
| author_facet | Jing S Lu Y Zhang J Ren Y Mo Y Liu D Duan L Yuan Z Wang C Wang Q |
| author_sort | Jing S |
| collection | DOAJ |
| description | Shangwen Jing,1,* Yantong Lu,1,2,* Jing Zhang,1 Yan Ren,1,2 Yousheng Mo,3 Dongdong Liu,3 Lining Duan,4 Zhongyu Yuan,5 Changjun Wang,2 Qi Wang1 1Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China; 2Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, People’s Republic of China; 3The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China; 4The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China; 5Department of Medical Oncology, Sun Yat-Sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, People’s Republic of China*These authors contributed equally to this workCorrespondence: Changjun Wang; Qi Wang, Email gzwchj@126.com; wangqi@gzucm.edu.cnIntroduction: Breast cancer (BC) is the leading female malignancy, with one million new cases diagnosed worldwide per year. However, the current treatment options for BC patients have difficulty achieving satisfactory efficacy. Ferroptosis is a new mode of regulated cell death that plays a key role in the inhibition of tumorigenesis. Levistilide A (LA), as an active compound extracted from Chuanxiong Rhizoma, might prevent the development of tumors by regulating the critical cellular processes of ferroptosis.Methods: In this study, the underlying mechanisms of LA on ferroptosis in BC were explored in vitro. The effect of LA on the viability and mitochondrial function of BC cells was determined. Moreover, the effect of LA on the expression levels of key molecules involved in ferroptosis and the nuclear factor erythroid-2-related factor 2/heme oxygenase 1 (Nrf2/HO-1) signaling pathway was evaluated.Results: LA significantly reduced cell viability and damaged the mitochondrial structure and function of BC cells in a dose-dependent manner. Furthermore, LA treatment markedly enhanced reactive oxygen species (ROS)-induced ferroptosis by activating the Nrf2/HO-1 signaling pathway.Conclusion: These findings suggest that LA may be a potential lead compound for breast cancer therapy by inducing ferroptosis in tumor cells.Keywords: breast cancer, levistilide A, ferroptosis, Nrf2/HO-1 signaling pathway |
| first_indexed | 2024-04-12T19:19:40Z |
| format | Article |
| id | doaj.art-92e6e1555a3341b6ba75e365f4a9a53c |
| institution | Directory Open Access Journal |
| issn | 1177-8881 |
| language | English |
| last_indexed | 2024-04-12T19:19:40Z |
| publishDate | 2022-09-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Drug Design, Development and Therapy |
| spelling | doaj.art-92e6e1555a3341b6ba75e365f4a9a53c2022-12-22T03:19:38ZengDove Medical PressDrug Design, Development and Therapy1177-88812022-09-01Volume 162981299378039Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer CellsJing SLu YZhang JRen YMo YLiu DDuan LYuan ZWang CWang QShangwen Jing,1,* Yantong Lu,1,2,* Jing Zhang,1 Yan Ren,1,2 Yousheng Mo,3 Dongdong Liu,3 Lining Duan,4 Zhongyu Yuan,5 Changjun Wang,2 Qi Wang1 1Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China; 2Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, People’s Republic of China; 3The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China; 4The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China; 5Department of Medical Oncology, Sun Yat-Sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, People’s Republic of China*These authors contributed equally to this workCorrespondence: Changjun Wang; Qi Wang, Email gzwchj@126.com; wangqi@gzucm.edu.cnIntroduction: Breast cancer (BC) is the leading female malignancy, with one million new cases diagnosed worldwide per year. However, the current treatment options for BC patients have difficulty achieving satisfactory efficacy. Ferroptosis is a new mode of regulated cell death that plays a key role in the inhibition of tumorigenesis. Levistilide A (LA), as an active compound extracted from Chuanxiong Rhizoma, might prevent the development of tumors by regulating the critical cellular processes of ferroptosis.Methods: In this study, the underlying mechanisms of LA on ferroptosis in BC were explored in vitro. The effect of LA on the viability and mitochondrial function of BC cells was determined. Moreover, the effect of LA on the expression levels of key molecules involved in ferroptosis and the nuclear factor erythroid-2-related factor 2/heme oxygenase 1 (Nrf2/HO-1) signaling pathway was evaluated.Results: LA significantly reduced cell viability and damaged the mitochondrial structure and function of BC cells in a dose-dependent manner. Furthermore, LA treatment markedly enhanced reactive oxygen species (ROS)-induced ferroptosis by activating the Nrf2/HO-1 signaling pathway.Conclusion: These findings suggest that LA may be a potential lead compound for breast cancer therapy by inducing ferroptosis in tumor cells.Keywords: breast cancer, levistilide A, ferroptosis, Nrf2/HO-1 signaling pathwayhttps://www.dovepress.com/levistilide-a-induces-ferroptosis-by-activating-the-nrf2ho-1-signaling-peer-reviewed-fulltext-article-DDDTbreast cancerlevistilide aferroptosisnrf2/ho-1 signaling pathway |
| spellingShingle | Jing S Lu Y Zhang J Ren Y Mo Y Liu D Duan L Yuan Z Wang C Wang Q Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells Drug Design, Development and Therapy breast cancer levistilide a ferroptosis nrf2/ho-1 signaling pathway |
| title | Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells |
| title_full | Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells |
| title_fullStr | Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells |
| title_full_unstemmed | Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells |
| title_short | Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells |
| title_sort | levistilide a induces ferroptosis by activating the nrf2 ho 1 signaling pathway in breast cancer cells |
| topic | breast cancer levistilide a ferroptosis nrf2/ho-1 signaling pathway |
| url | https://www.dovepress.com/levistilide-a-induces-ferroptosis-by-activating-the-nrf2ho-1-signaling-peer-reviewed-fulltext-article-DDDT |
| work_keys_str_mv | AT jings levistilideainducesferroptosisbyactivatingthenrf2ho1signalingpathwayinbreastcancercells AT luy levistilideainducesferroptosisbyactivatingthenrf2ho1signalingpathwayinbreastcancercells AT zhangj levistilideainducesferroptosisbyactivatingthenrf2ho1signalingpathwayinbreastcancercells AT reny levistilideainducesferroptosisbyactivatingthenrf2ho1signalingpathwayinbreastcancercells AT moy levistilideainducesferroptosisbyactivatingthenrf2ho1signalingpathwayinbreastcancercells AT liud levistilideainducesferroptosisbyactivatingthenrf2ho1signalingpathwayinbreastcancercells AT duanl levistilideainducesferroptosisbyactivatingthenrf2ho1signalingpathwayinbreastcancercells AT yuanz levistilideainducesferroptosisbyactivatingthenrf2ho1signalingpathwayinbreastcancercells AT wangc levistilideainducesferroptosisbyactivatingthenrf2ho1signalingpathwayinbreastcancercells AT wangq levistilideainducesferroptosisbyactivatingthenrf2ho1signalingpathwayinbreastcancercells |